Clinical Trial

Clinical Performance and Safety of STYLAGE® HydroMax

Study acronym: FHAME
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 10, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
FHAME is a post-market clinical investigation designed to strengthen the clinical evidence supporting the effectiveness of STYLAGE® HydroMax in the treatment of superficial wrinkles, primarily on the cheeks.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-29.
Trial Details
NCT Number NCT07153237
Lead Sponsor Laboratoires Vivacy
Collaborators: Quantificare SA, Eurofins Dermscan Pharmascan, Inferential, International Clinical Trials Association
Conditions Aging, Aesthetic
Enrollment 81 participants
Start Date 2025-09-09
Primary Completion 2026-03 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-09-10